Back to search
FDAFDA · Food and drugs·Recall number D-1058-2014

Glucotrol XL (glipizide) extended release tablets, 5 mg, 100 count bottles, Rx only, Distributed by Roerig, Division of Pfizer Inc, NY, NY --- NDC 0049-1550-66

Published February 12, 2014 · Recall initiated: November 4, 2013

Summary

FDA records drug Class III recall D-1058-2014, published February 12, 2014 and initiated November 4, 2013. Recalling firm: Pfizer Inc.; Status: Terminated; Reported quantity: 14,357 bottles; Lot: Lot V120131. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specification; 8 hr stability timepoint

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Pfizer Inc.
Distributor
US nationwide (including PR)
Lot
Lot V120131
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Glucotrol XL (glipizide) extended release tablets, 5 mg, 100 count bottles, Rx only, Distributed by Roerig, Division of Pfizer Inc, NY, NY --- NDC 0049-1550-66 recalled?

Yes. FDA published recall D-1058-2014 on February 12, 2014. Reported hazard: Failed Dissolution Specification; 8 hr stability timepoint

What should I do if I have this product?

Voluntary: Firm initiated · Letter